MARKET_TICKER: REGN

REGENERON PHARMACEUTICAInsider Trading & SEC Form 4 Analysis

Institutional analysis of internal capital flows based on SEC Form 4 filings.

Executive Sentiment
BEARISH
SOURCE: EDGAR_SYSTEMSTATUS: VERIFIED
Net_Flow

-$4.5M

Buys minus sales
Last_Filing

2026.07.02

Latest Form 4
Active_Insiders

17

Reporting entities
Top_Buyer

No buyer detected

No open-market buys
Top_Seller

Bassler Bonnie L

$1.2M

Automated_Intelligence_Report :: REGN

Algorithmic analysis of recent insider trading activity for REGN reveals a bearish posture among the C-suite and board members. Based on the latest SEC Form 4 filings, we have tracked capital events executed by 17 distinct corporate insiders. The aggregate nominal exposure during this reporting cycle reached $446.31M.

Market dynamics show a negative net capital flow of $4.50M when isolating open-market purchases versus open-market sales. Interestingly, a significant portion of the total volume is driven by the exercise of options or grants rather than open-market transactions, suggesting that insiders are currently prioritizing compensation-based equity accumulation or tax-related liquidation over voluntary portfolio rebalancing.

From a microstructural perspective, the most significant liquidity event was a divestment by Bassler Bonnie L (Director), which accounts for a major share of the recent outflow. Continuous monitoring of these Tier-1 actors is essential, as their liquidity decisions often precede material corporate events or reflect an informed, asymmetric perspective on the future performance of REGN.

Volume_30D

$446.31M

USD NOMINAL VALUE
Active_Insiders

17

UNIQUE C-SUITE ENTITIES
Last_Entry

2026.07.02

ISO_8601 FORMAT
Loading chart...
Entity / TimelineMethodologyPositionNet Value
RYAN ARTHUR F2026.07.02
DISPOSAL200$130,030
RYAN ARTHUR F2026.05.01
DISPOSAL5$3,508.8
RYAN ARTHUR F2026.05.01
DISPOSAL15$10,536.9
RYAN ARTHUR F2026.05.01
DISPOSAL24$16,883.04
RYAN ARTHUR F2026.05.01
DISPOSAL15$10,564.2
RYAN ARTHUR F2026.05.01
DISPOSAL14$9,877.84
RYAN ARTHUR F2026.05.01
DISPOSAL7$4,947.18
RYAN ARTHUR F2026.05.01
DISPOSAL4$2,829.6
RYAN ARTHUR F2026.05.01
DISPOSAL6$4,256.7
RYAN ARTHUR F2026.05.01
DISPOSAL2$1,421.74
RYAN ARTHUR F2026.05.01
DISPOSAL5$3,557.45
RYAN ARTHUR F2026.05.01
DISPOSAL1$712.09
RYAN ARTHUR F2026.05.01
DISPOSAL2$1,428.26
RYAN ARTHUR F2026.04.01
DISPOSAL1$771.32
RYAN ARTHUR F2026.04.01
DISPOSAL3$2,318.28
RYAN ARTHUR F2026.04.01
DISPOSAL8$6,188.72
RYAN ARTHUR F2026.04.01
DISPOSAL8$6,196.64
RYAN ARTHUR F2026.04.01
DISPOSAL14$10,858.12
RYAN ARTHUR F2026.04.01
DISPOSAL13$10,096.06
RYAN ARTHUR F2026.04.01
DISPOSAL9$6,996.78
PAGE_ 1 _OF_ 5

Automated_Queries :: Frequently Asked Questions

>Who is currently buying REGN stock?

Our algorithmic tracking of SEC Form 4 filings indicates no significant open-market buying activity by major executives for REGN in the recent reporting period.

>Are REGN insiders selling their shares?

Yes, we have tracked $4.50M in recent insider liquidations. The most notable recent seller is Bassler Bonnie L, who executed the largest single offload.

>What is the overall insider sentiment for REGN?

The short-term structural capital flow indicates a BEARISH sentiment, with a net flow of $4.50M generated by 17 active C-Suite entities.

Related_Analysis

SECTOR_PEERS :: Healthcare